Optimal analgesia with remifentanil for patients requiring postoperative intensive care.
Not Applicable
- Conditions
- Admission to the Surgical Intensive Care Unit (SICU) after surgery under general anesthesia.
- Registration Number
- JPRN-UMIN000051558
- Lead Sponsor
- Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
A) Cases with atrial fibrillation. B) Cases in which it is inappropriate to perform the observation arterial manometry in the radial artery. C) Patients with significant hemodynamic or neurologic impairment in the upper extremities. D) Patients with severe stenosis or occlusive lesions in cerebral vessels. E) Cases with contraindications to remifentanil, propofol, or rocuronium. F) Patients who are regularly using opioids. G) Cases in which prior consent has been withdrawn. H) Cases in which the anesthesiologist deems the patient unfit to perform this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation between MECK and remifentanil dosage
- Secondary Outcome Measures
Name Time Method Time required for remifentanil dosing rate to stabilize.